Cortexyme
Cortexyme is a California-based biopharmaceutical company that develops disease-modifying therapeutics for the treatment of neurodegenerative and Alzheimer’s diseases.
Business Model:
Revenue: $167M
Employees: 51-200
Industries / Tags:
Detailed Cortexyme Information
Geographic Data
Address: 269 East Grand Avenue
City: South San Francisco
State: CA
Zip: 94080
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$125M
Raised Total:$225M
Social
Metrics
3,040,583Website Global Rank
5,697Website Monthly Traffic
Twitter Followers
Description
Cortexyme is a California-based biopharmaceutical company that develops disease-modifying therapeutics for the treatment of neurodegenerative and Alzheimer’s diseases.
Contact Phone:
+14159105717
Contact Email:
Cortexyme went public on 5/8/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/8/2019
IPO Valuation:
$442M
Ticker Symbol:
CRTX
IPO Price:
$17/share
Amount Raised:
$75M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 5/2022 | Novosteo |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
